Senor Catface
Registered User
- Jul 25, 2006
- 16,002
- 20,036
And now for the hardest part and the point where most of new experimental drugs etc fall apart. As in, when they’re tested on actual humans and not little lab animals. And the time of testing will take a while before it can be confirmed some type of success.
Read the article. They're entering phase 3 testing (large cohorts with diverse populations), not transitioning from preclinical animal studies to phase 1 clinical (start of human clinical trials). They've even refined their dosing protocol, which occurs in early clinical human trials, and demonstrated early human efficacy with key biomarkers.And now for the hardest part and the point where most of new experimental drugs etc fall apart. As in, when they’re tested on actual humans and not little lab animals. And the time of testing will take a while before it can be confirmed some type of success.
Read the article. They're entering phase 3 testing (large cohorts with diverse populations), not transitioning from preclinical animal studies to phase 1 clinical (start of human clinical trials). They've even refined their dosing protocol, which occurs in early clinical human trials, and demonstrated early human efficacy with key biomarkers.
Yeah, I follow this website and have a subscription to GlobalData Healthcare email updates through work.
Not trying to be a Negative Nell, but how long do you think is a sufficient amount of time for a vaccine to be declared an absolute success?Read the article. They're entering phase 3 testing (large cohorts with diverse populations), not transitioning from preclinical animal studies to phase 1 clinical (start of human clinical trials). They've even refined their dosing protocol, which occurs in early clinical human trials, and demonstrated early human efficacy with key biomarkers.
We'll know the answer to that question when the phase 3 results are unblinded for this and other vaccine candidates. One should also follow the literature on the impact of SARS-CoV-2 antibodies (and other factors) on preventing reinfection.Not trying to be a Negative Nell, but how long do you think is a sufficient amount of time for a vaccine to be declared an absolute success?
I guess I’m looking for is your opinion on what time frame you would feel comfortable with?We'll know the answer to that question when the phase 3 results are unblinded for this an other vaccine candidates. One should also follow the literature on the impact of SARS-CoV-2 antibodies (and other factors) on preventing reinfection.
It remains complex set of variable to weigh at this point and it's why I hesitate to answer until I can review the data (and more importantly have independent experts at the FDA do the same). One has to look at what biomarkers they target (e.g., antibodies) and the statistics of how they induce them across the different cohorts through the dosing protocol they choose. Incidence rate and severity of side effects must also be quantified.I guess I’m looking for is your opinion on what time frame you would feel comfortable with?
Were they social distancing? I mean, was there enough room to avoid people and keep some distance?
And now for the hardest part and the point where most of new experimental drugs etc fall apart. As in, when they’re tested on actual humans and not little lab animals. And the time of testing will take a while before it can be confirmed some type of success.
I don't know... this seems like a bad bad idea.... 300 people in MKT, cheering and whooping it up, creating aerosols in an enclosed restaurant for several hours? Prepare for an even bigger bump in numbers I guess. At this point i'm almost preparing for a re-shutdown (rec centers, rinks, some non-essential facilities etc) come fall/winter.
Phase 2 testing is human testing. This is moving to phase 3. It's already shown promising results in stimulating protective antibodies in humans. Phase 3 is about testing a crowd of people. They will give the vaccine to them and send them out for a couple months. If they come back with antibodies and low/no infection, it will be about monitoring side effects and testing for safety in Phase 4.
There's no guarantee it will be effective but it's nice that a second vaccine (the Oxford vaccine entered Phase 3 testing last month) is showing some promise.
I have very little doubt that whenever we get to a vaccine, it will be the fastest we've ever done it. There has never been so many with so much investment racing towards a vaccine.
Alberta is already the worst province per capita for new infections so I don't doubt that this is in the cards for us.
A large number of those new cases are coming from Edmonton, which thankfully looks like it’s stabilized and trending down again over the last few days.
Cases in Edmonton seem to have slightly stabilized since more than doubling in June, and the outbreak at Mis has and will be costly, but Alberta as a whole (in particular Calgary) is clearly as bad as it's been in over two months. The last three days have been the worst since May 9th and it's trending up.
I don't know... this seems like a bad bad idea.... 300 people in MKT, cheering and whooping it up, creating aerosols in an enclosed restaurant for several hours? Prepare for an even bigger bump in numbers I guess. At this point i'm almost preparing for a re-shutdown (rec centers, rinks, some non-essential facilities etc) come fall/winter.